ThePrint on MSN2 天
Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025
Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...